PRMT1 and metabolic dysfunction-associated steatotic liver disease: Although very little is known about the chronic knockdown or inhibition of hepatic PRMT1 in energy metabolism of obese subjects, targeting of hepatic PRMT1 has been proposed a treatment of NAFLD 24.